Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT

NCT05014594 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis
Ascites Hepatic

Interventions

DRUG: Dapagliflozin (10Mg Tab) along with standard medical therapy
DRUG: Placebo of dapaglifozin along with standard medical therapy

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh